Sirna to Close $18M Private Placement | GenomeWeb

NEW YORK, April 30 (GenomeWeb New) - Sirna Therapeutics announced today that it has made agreements with institutional investors for the private placement of $18 million, or $3.25 per share, worth of common stock.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.